Position in SVRA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,991,605
+$153,842 QoQ
Shares Held
364,763
+19.7% QoQ
Ownership
0.178%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#55
of 184 holders
Holding Since
Sep 2020
15 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in SVRA Over Time
Shares Held
Position Value (USD)
Derivatives in SVRA
reported options exposure · as of Jun 30, 2024CallValue
$0
CallShares
0
PutValue
$604,500
PutShares
150,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Sofinnova Investments, Inc. holds $1,145,092,748 across 48 Biotechnology names. SVRA ranks #39 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
598,327 | $113,113,719 | |
| 2 | VERA |
Vera Therapeutics, Inc.
|
2,793,987 | $112,402,097 | |
| 3 | COGT |
Cogent Biosciences, Inc.
|
2,113,551 | $81,350,577 | |
| 4 | RARE |
Ultragenyx Pharmaceutical Inc.
|
3,145,888 | $65,906,353 | |
| 5 | RAPP |
Rapport Therapeutics, Inc.
|
1,904,408 | $59,588,926 | |
| 6 | INSM |
INSMED Inc
|
346,075 | $56,590,184 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
781,982 | $44,174,163 | |
| 8 | CELC |
Celcuity Inc.
|
366,175 | $41,795,214 |
All Filings in SVRA
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,991,605 | 364,763 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,837,763 | 304,770 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $8,666,974 | 2,427,724 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $5,602,762 | 2,457,352 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $15,184,214 | 5,481,666 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $16,796,887 | 5,471,299 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $24,009,212 | 5,662,550 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $604,500 | 150,000 | Put | Sole | 2024-08-09 | |
| 2024-06-30 | $21,596,439 | 5,358,918 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $11,689,359 | 2,347,261 | Shares | Sole | 2024-08-14 | |
| 2023-12-31 | $11,199,324 | 2,382,835 | Shares | Sole | 2024-08-15 | |
| 2023-09-30 | $596,892 | 157,908 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $307,512 | 96,248 | Shares | Sole | 2023-08-14 | |
| 2021-06-30 | $2,173,320 | 1,278,424 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $3,613,896 | 1,737,450 | Shares | Sole | 2021-05-14 | |
| 2020-09-30 | $409,393 | 375,591 | Shares | Other | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||